Sarumathy Sundararajan

Deciphering the Multi-Target Mechanisms of Imeglimin in Type 2 Diabetes Mellitus Through Integrated Network Pharmacology, Molecular Docking, and Molecular Dynamics Simulation

Type 2 diabetes mellitus (T2DM) is a complex metabolic disorder involving insulin resistance, impaired glucose metabolism, mitochondrial dysfunction, and chronic inflammation. Imeglimin is a novel oral antidiabetic agent that improves mitochondrial function and insulin sensitivity, although its precise molecular mechan...